November 27, 2022
Loading...
You are here:  Home  >  Health Care & Life Science  -  Page 4
Latest

Inogen beats Q2 estimates, but shares still drop

By   /  Monday, August 8th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Santa Barbara County, Subscriber content, Top Stories, Tri-County Public Companies  /  Comments Off on Inogen beats Q2 estimates, but shares still drop

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Amgen beats analysts’ expectations for earnings and revenue in Q2

By   /  Thursday, August 4th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Subscriber content, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Amgen beats analysts’ expectations for earnings and revenue in Q2

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Amgen to buy ChemoCentryx for $3.7B

By   /  Thursday, August 4th, 2022  /  Banking & Finance, Health Care & Life Science, Latest news, left, Regions, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Amgen to buy ChemoCentryx for $3.7B

Amgen was having a relatively quiet year on the mergers and acquisitions front, at least until Aug. 4, when the Thousand Oaks-based biotech firm announced it will purchase ChemoCentryx for nearly $3.7 billion. ChemoCentryx is a Silicon Valley biopharmaceutical company focused on orally administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. It has Read More →

Latest

Arcutis to raise $150M in public stock offering

By   /  Wednesday, August 3rd, 2022  /  Banking & Finance, Health Care & Life Science, Latest news, Regions, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Arcutis to raise $150M in public stock offering

Arcutis Biotherapeutics, a Westlake Village-based company developing drugs for immune dermatological conditions, plans to raise $150 million through a public offering of additional shares of common stock. Arcutis announced the pricing of those shares on Aug. 2, at $20 per share. Shares of Arcutis closed at $19.50 that day and then shot up 17% on Read More →

Latest

Cure sells $20M in intellectual property, replaces CEO and CFO

By   /  Monday, August 1st, 2022  /  Banking & Finance, Health Care & Life Science, Latest news, Regions, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Cure sells $20M in intellectual property, replaces CEO and CFO

Oxnard-based Cure Pharmaceutical, a drug delivery platform and CBD products company, will be selling a portion of its intellectual property and related assets for $20 million, the company announced July 28. The buyer was a company called TF Tech Ventures, and the deal closed July 22, Cure said in a July 28 filing with the Read More →

Latest

Community Health Centers honored for safety net and pandemic programs

By   /  Monday, July 18th, 2022  /  Health Care & Life Science, Latest news, Regions, San Luis Obispo County, Santa Barbara County, Subscriber content, Top Stories  /  Comments Off on Community Health Centers honored for safety net and pandemic programs

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Oma Fertility raises $37.5M in quest to revolutionize IVF treatment

By   /  Friday, July 8th, 2022  /  Health Care & Life Science, Latest news, Regions, Santa Barbara County, Startups, Subscriber content, Top Stories  /  Comments Off on Oma Fertility raises $37.5M in quest to revolutionize IVF treatment

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.